November is Diabetes Awareness Month, and this year Diabetes Canada is launching a new campaign to confront the stigma faced ...

Toronto, Oct. 21, 2025 (GLOBE NEWSWIRE) -- At a media conference at the Ontario Legislature today, Diabetes Canada announced the launch of a nationwide advocacy campaign aimed at ensuring consistent, ...

This Diabetes Awareness Month, Diabetes Canada is calling on all people in Canada to learn the facts, challenge harmful beliefs, and stand with the diabetes community. Canadians are encouraged to ...

OTTAWA — As the federal Liberals consider a path forward for a national pharmacare plan, one advocacy group is calling on the government to rethink the program to make it work better for patients and ...

The high price of insulin across the country is forcing some families with type 1 diabetes to go north to buy the medication. From 2012 to 2016, the price of insulin nearly doubled in the U.S. — and ...

MISSISSAUGA, ON, Aug. 21 /CNW/ - Takeda Canada, Inc. announced that it has reacquired the Canadian commercial rights to ACTOS(R) (pioglitazone HCl), an oral treatment for type 2 diabetes, from Eli ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps, today announced its submission of a medical ...

MISSISSAUGA, ON, Oct. 18, 2013 /CNW/ - Novo Nordisk today announced that Health Canada has approved Levemir® FlexTouch®, a disposable prefilled insulin pen containing Levemir® (insulin detemir).

MISSISSAUGA, ON, Aug. 19, 2025 /CNW/ - Novo Nordisk announced today that Ozempic ® (semaglutide injection) is now approved as the first-and-only medication indicated for both the once-weekly treatment ...